Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
Condition: HIV InfectionsInterventions: Drug: 1% tenofovir gel; Drug: Placebo gelSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Withdrawn - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Aci-Jel | Allergy | Allergy & Immunology | Infectious Diseases | Pregnancy | Research | Viread | Women